Literature DB >> 20808074

Alterations in arterial pressure in patients with Type 1 diabetes are associated with long-term poor metabolic control and a more atherogenic lipid profile.

F J Vílchez-López1, F Carral-Sanlaureano, C Coserria-Sánchez, A Nieto, S Jiménez, M Aguilar-Diosdado.   

Abstract

AIM: To determine the prevalence of alterations in blood pressure (BP) in patients with Type 1 diabetes who are normoalbuminuric and normotensive; and to evaluate the association with genetic, clinical and metabolic factors. MATERIAL/
METHODS: Normoalbuminuric, normotensive Type 1 diabetic patients (no.=85) had their ambulatory blood pressure monitoring (ABPM) performed over 24 h, together with measurement of HbA1c and lipid profile, polymorphisms of the ACE gene, non-midriatic retinography, and the "historical HbA1c" calculated (mean of all the determinations available on the patient).
RESULTS: Of the 85 patients, a mean of 18.8% had pathologic values of BP over the 24 h, 31.8% during active periods and 22.4% during rest periods; in 42% there was a non-dipper pattern in BP. The patients with alterations of BP had higher body mass index (BMI), higher levels of glycemia and of triglycerides, and decreased levels of HDL cholesterol. The "historical HbA1c" was significantly higher in the patients with the non-dipper pattern (8.6 ± 1.4% vs 7.9 ± 1.4%; p=0.046). Pulse pressure was directly associated with male gender (p=0.006) and with BMI (p=0.001). No differences were detected in the distribution of the polymorphisms of the ACE gene as a function of the BP alterations.
CONCLUSIONS: An elevated number normoalbuminuric, normotensive, Type 1 diabetic patients have alterations in BP detected with ABPM over 24 h, and these are associated with a greater BMI, poor long-term metabolic control and a more atherogenic lipid profile.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20808074     DOI: 10.1007/BF03347057

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Thomas Pickering; Roland Asmar; Martin Myers; Gianfranco Parati; Jan Staessen; Thomas Mengden; Yutaka Imai; Bernard Waeber; Paolo Palatini; William Gerin
Journal:  Blood Press Monit       Date:  2002-02       Impact factor: 1.444

2.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

3.  Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes.

Authors:  V Spallone; M R Maiello; E Cicconetti; A Pannone; A Barini; S Gambardella; G Menzinger
Journal:  J Hum Hypertens       Date:  2001-04       Impact factor: 3.012

4.  Alterations of blood pressure in type 1 diabetic children and adolescents.

Authors:  Sukran Darcan; Damla Goksen; Sevgi Mir; Erkin Serdaroglu; Muammer Buyukinan; Mahmut Coker; Afig Berdeli; Timur Köse; Alphan Cura
Journal:  Pediatr Nephrol       Date:  2006-03-28       Impact factor: 3.714

5.  Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.

Authors:  V R Sørensen; E R Mathiesen; P Clausen; A Flyvbjerg; B Feldt-Rasmussen
Journal:  Diabet Med       Date:  2005-07       Impact factor: 4.359

6.  Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age.

Authors:  Cesare Cuspidi; Stefano Meani; Cristiana Valerio; Carla Sala; Veronica Fusi; Meilikemu Masaidi; Alberto Zanchetti; Giuseppe Mancia
Journal:  Blood Press Monit       Date:  2007-04       Impact factor: 1.444

7.  Association of angiotensin-converting enzyme DD genotype with 24-h blood pressure abnormalities in normoalbuminuric children and adolescents with Type 1 diabetes.

Authors:  L Barkai; A Soós; I Vámosi
Journal:  Diabet Med       Date:  2005-08       Impact factor: 4.359

8.  Circadian blood pressure levels in normotensive normoalbuminuric type 1 diabetic patients.

Authors:  R Sivieri; M Deandrea; V Gai; P Cavallo-Perin
Journal:  Diabet Med       Date:  1994-05       Impact factor: 4.359

9.  Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes.

Authors:  J C Philips; M Marchand; A J Scheen
Journal:  Diabetes Metab Res Rev       Date:  2009-07       Impact factor: 4.876

10.  Diurnal variation of blood pressure in adolescents with type 1 diabetes: dippers and non-dippers.

Authors:  N Khan; J J Couper
Journal:  Diabet Med       Date:  1996-06       Impact factor: 4.359

View more
  4 in total

1.  Early blood pressure alterations are associated with pro-inflammatory markers in type 1 diabetes mellitus.

Authors:  I Mateo-Gavira; F J Vílchez-López; M V García-Palacios; F Carral-San Laureano; F M Visiedo-García; M Aguilar-Diosdado
Journal:  J Hum Hypertens       Date:  2016-08-18       Impact factor: 3.012

2.  Non-dipping and arterial hypertension depend on clinical factors rather than on genetic variability of ACE and RGS2 genes in patients with type 1 diabetes.

Authors:  G Deja; M Borowiec; W Fendler; I Pietrzak; A Szadkowska; L Machnica; J Polanska; W Mlynarski; P Jarosz-Chobot
Journal:  Acta Diabetol       Date:  2014-02-23       Impact factor: 4.280

3.  Early changes in cardiovascular structure and function in adolescents with type 1 diabetes.

Authors:  Timothy J Bradley; Cameron Slorach; Farid H Mahmud; David B Dunger; John Deanfield; Livia Deda; Yesmino Elia; Ronnie L H Har; Wei Hui; Rahim Moineddin; Heather N Reich; James W Scholey; Luc Mertens; Etienne Sochett; David Z I Cherney
Journal:  Cardiovasc Diabetol       Date:  2016-02-16       Impact factor: 9.951

4.  Association between central non-dipping pattern and platelet morphology in adults with type 1 diabetes without cardiovascular disease: a cross-sectional study.

Authors:  Michal Kulecki; Dariusz Naskret; Mikolaj Kaminski; Dominika Kasprzak; Pawel Lachowski; Daria Klause; Maria Kozlowska; Justyna Flotynska; Aleksandra Uruska; Dorota Zozulinska-Ziolkiewicz
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.